TABLE 1.
An overview of PET studies reporting cerebral metabolic rate for glucose (CMRg) in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Owing to the different study designs, it is difficult to derive the mean difference in CMRg in AD versus controls but it is on the order of 25%, and somewhat less in MCI.
Reference | n in each group | Atrophy correction | CMRga |
---|---|---|---|
Frackowiak et al (1981)208 | n = 14 HC n = 13 AD n = 9 VD |
No | 28% ↓ in grey matter 23% ↓ in white matter for AD & VD |
Benson et al (1983)209 | n = 16 HC n = 8 AD |
No | ↓ 49% for AD |
Cutler et al (1985)210 | n = 25 HC n = 5 mild to moderate AD n = 2 severe AD |
No | 25–50% ↓ for severe AD in frontal, parietal, temporal, occipital lobes compared to mild-mod AD & HC |
Rapoport et al (1986)211 | n = 10 HC n = 47 mild to moderate AD |
No | 18–31% ↓ for AD |
Chawluk et al (1987)212 | n = 17 HC n = 24 AD |
Yes | 8% ↓ for AD |
Alavi et al (1993)213 | n = 17 HC n = 20 AD |
Yes | 11 % ↓ for AD |
Mielke et al (1994)214 | n = 13 HC n = 20 AD |
No | ↓ for AD in temporoparietal and occipital cortex |
Metzler et al (1996)215 | n = 10 HC n = 8 AD |
Yes | ↓ for AD in frontal, temporal and posterior parietal lobes |
Hock et al (1997)52 | n = 17 HC n = 19 AD |
No | ↓ for AD in parietal lobe |
Ibanez et al (1998)48 | n = 19 HC n = 5 mild AD n = 6 moderate AD n = 4 severe AD |
Yes | ↓ for AD in precuneaus and posterior cingulate cortex |
Mosconi et al (2005)50 | n = 11 HC n = 13 MCI n = 12 AD |
Yes | 18% ↓ for MCI 27% ↓ for AD in hippocampus compared with HC |
Minoshima et al (2007)216 | n = 22 HC n = 8 AD |
Yes | 20–21% ↓ for AD in posterior cingulate and cinguloparietal transitional area |
Li et al (2008)37 | n = 7 HC n = 13 aMCI n = 17 AD |
No | in AD; gray matter (11% ↓), hippocampus (30% ↓), inferior parietal lobe (15% ↓), middle frontal gyrus (12% ↓), posterior cingulate (17% ↓) in aMCI; hippocampus (14% ↓) and inferior parietal lobe (11% ↓) |
Del Sole et al (2008)58 | n = 7 HC n = 16 aMCI n = 14 AD |
No | ↓ for AD in posterior cingulate, precuneaus, & parietal & temporal lobes ↓ for aMCI in posterior cingulate |
Ishii et al (2009)66 | n = 42 MCI who converted to AD within 5 y | No | ↓ for AD in right cingulate, left inferior lobe & left temporal gyrus |
HC – healthy controls (commonly but not always well matched for age, education). Comorbidities, i.e. hypertension, not always excluded or controlled for, especially in earlier studies.
MCI – mild cognitive impairment, type not specified
aMCI – amnestic MCI
AD – Alzheimer’s disease, usually defined as 〈probable〉 AD, Most common criteria are those of the National Institute of Neurological and Communicable Diseases and Stroke, Alzheimer’s Disease and Related Dementias Association (NINCDS-ADRDA)
CMRg – cerebral metabolic rate for glucose
VD – vascular dementia
difference versus healthy controls